Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p580 has 84 genes in the original annotation. Currently, there are 61 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
2625	GATA3	HDR \| HDRS	GATA binding protein 3	10p15
6688	SPI1	OF \| PU.1 \| SFPI1 \| SPI-1 \| SPI-A	Spi-1 proto-oncogene	11p11.2
4654	MYOD1	MYF3 \| MYOD \| PUM \| bHLHc1	myogenic differentiation 1	11p15.4
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
330	BIRC3	AIP1 \| API2 \| CIAP2 \| HAIP1 \| HIAP1 \| MALT2 \| MIHC \| RNF49 \| c-IAP2	baculoviral IAP repeat containing 3	11q22
2113	ETS1	ETS-1 \| EWSR2 \| c-ets-1 \| p54	ETS proto-oncogene 1, transcription factor	11q23.3
3312	HSPA8	HEL-33 \| HEL-S-72p \| HSC54 \| HSC70 \| HSC71 \| HSP71 \| HSP73 \| HSPA10 \| LAP-1 \| LAP1 \| NIP71	heat shock protein family A (Hsp70) member 8	11q24.1
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
920	CD4	CD4mut	CD4 molecule	12p13.31
7471	WNT1	BMND16 \| INT1 \| OI15	wingless-type MMTV integration site family member 1	12q13
6667	SP1	-	Sp1 transcription factor	12q13.1
4618	MYF6	CNM3 \| MRF4 \| bHLHc4 \| myf-6	myogenic factor 6	12q21
490	ATP2B1	PMCA1 \| PMCA1kb	ATPase plasma membrane Ca2+ transporting 1	12q21.3
7329	UBE2I	C358B7.1 \| P18 \| UBC9	ubiquitin conjugating enzyme E2 I	16p13.3
1387	CREBBP	CBP \| KAT3A \| RSTS	CREB binding protein	16p13.3
4094	MAF	AYGRP \| CCA4 \| CTRCT21 \| c-MAF	v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog	16q22-q23
463	ZFHX3	ATBF1 \| ATBT \| ZNF927	zinc finger homeobox 3	16q22.3
161882	ZFPM1	FOG \| FOG1 \| ZC2HC11A \| ZNF408 \| ZNF89A	zinc finger protein, FOG family member 1	16q24.2
51701	NLK	-	nemo-like kinase	17q11.2
4353	MPO	-	myeloperoxidase	17q23.1
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
5657	PRTN3	ACPA \| AGP7 \| C-ANCA \| CANCA \| MBN \| MBT \| NP-4 \| NP4 \| P29 \| PR-3 \| PR3	proteinase 3	19p13.3
1050	CEBPA	C/EBP-alpha \| CEBP	CCAAT/enhancer binding protein alpha	19q13.1
10155	TRIM28	KAP1 \| PPP1R157 \| RNF96 \| TF1B \| TIF1B	tripartite motif containing 28	19q13.4
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
2944	GSTM1	GST1 \| GSTM1-1 \| GSTM1a-1a \| GSTM1b-1b \| GTH4 \| GTM1 \| H-B \| MU \| MU-1	glutathione S-transferase mu 1	1p13.3
6497	SKI	SGS \| SKV	SKI proto-oncogene	1p36.33
10401	PIAS3	ZMIZ5	protein inhibitor of activated STAT 3	1q21
5743	PTGS2	COX-2 \| COX2 \| GRIPGHS \| PGG/HS \| PGHS-2 \| PHS-2 \| hCox-2	prostaglandin-endoperoxide synthase 2	1q25.2-q25.3
947	CD34	-	CD34 molecule	1q32
100	ADA	-	adenosine deaminase	20q13.12
2114	ETS2	ETS2IT1	ETS proto-oncogene 2, transcription factor	21q22.2
10043	TOM1	-	target of myb1 membrane trafficking protein	22q13.1
10454	TAB1	3'-Tab1 \| MAP3K7IP1	TGF-beta activated kinase 1/MAP3K7 binding protein 1	22q13.1
2033	EP300	KAT3B \| RSTS2 \| p300	E1A binding protein p300	22q13.2
3280	HES1	HES-1 \| HHL \| HRY \| bHLHb39	hes family bHLH transcription factor 1	3q28-q29
3815	KIT	C-Kit \| CD117 \| PBT \| SCFR	KIT proto-oncogene receptor tyrosine kinase	4q12
5530	PPP3CA	CALN \| CALNA \| CALNA1 \| CCN1 \| CNA1 \| PPP2B	protein phosphatase 3 catalytic subunit alpha	4q24
3015	H2AFZ	H2A.Z-1 \| H2A.z \| H2A/z \| H2AZ	H2A histone family member Z	4q24
839	CASP6	MCH2	caspase 6	4q25
51176	LEF1	LEF-1 \| TCF10 \| TCF1ALPHA \| TCF7L3	lymphoid enhancer binding factor 1	4q25
5481	PPID	CYP-40 \| CYPD	peptidylprolyl isomerase D	4q31.3
1436	CSF1R	C-FMS \| CD115 \| CSF-1R \| CSFR \| FIM2 \| FMS \| HDLS \| M-CSF-R	colony stimulating factor 1 receptor	5q32
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
5292	PIM1	PIM	Pim-1 proto-oncogene, serine/threonine kinase	6p21.2
6885	MAP3K7	MEKK7 \| TAK1 \| TGF1a	mitogen-activated protein kinase kinase kinase 7	6q15
4602	MYB	Cmyb \| c-myb \| c-myb_CDS \| efg	MYB proto-oncogene, transcription factor	6q22-q23
8379	MAD1L1	MAD1 \| PIG9 \| TP53I9 \| TXBP181	MAD1 mitotic arrest deficient-like 1 (yeast)	7p22
1021	CDK6	MCPH12 \| PLSTIRE	cyclin-dependent kinase 6	7q21-q22
1278	COL1A2	OI4	collagen type I alpha 2	7q22.1
22797	TFEC	TCFEC \| TFE-C \| TFEC-L \| TFECL \| bHLHe34 \| hTFEC-L	transcription factor EC	7q31.2
27044	SND1	TDRD11 \| p100	staphylococcal nuclease and tudor domain containing 1	7q31.3
28996	HIPK2	PRO0593	homeodomain interacting protein kinase 2	7q34
1052	CEBPD	C/EBP-delta \| CELF \| CRP3 \| NF-IL6-beta	CCAAT/enhancer binding protein delta	8p11.2-p11.1
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
1211	CLTA	LCA	clathrin light chain A	9p13
5079	PAX5	ALL3 \| BSAP	paired box 5	9p13
1029	CDKN2A	ARF \| CDK4I \| CDKN2 \| CMM2 \| INK4 \| INK4A \| MLM \| MTS-1 \| MTS1 \| P14 \| P14ARF \| P16 \| P16-INK4A \| P16INK4 \| P16INK4A \| P19 \| P19ARF \| TP16	cyclin-dependent kinase inhibitor 2A	9p21
6595	SMARCA2	BAF190 \| BRM \| NCBRS \| SNF2 \| SNF2L2 \| SNF2LA \| SWI2 \| Sth1p \| hBRM \| hSNF2a	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	9p22.3